Tilray (NASDAQ: TLRY), Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) and Cronos Group (NASDAQ: CRON) were recently noted as three pure-play marijuana stocks currently listed on U.S. stock exchanges in an article on Fool.com titled, “The Marijuana Stock That Wall Street Likes the Most” authored by Keith Speights. Per the article, Tilray has been ranked as a “strong buy” by analysts at Cowen & Company, Northland Capital, and Roth Capital. Zacks Investment Research referenced Cowen & Company and GMP Securities in its list of analysts covering Canopy Growth, which received “buy” or “strong buy” ratings as well. Cronos Group, however, was covered only by two Canadian investment firms. At the end of the day, Wall Street analysts seem to be the most bullish on the company that has delivered the best stock performance, which is Tilray. The article noted that Tilray may be enticing investors’ because of its potential to land the next major deal, perhaps with Diageo (NYSE: DEO), a multinational alcoholic beverages company that is reportedly seeking a cannabis partner.
To view the full article, visit http://cnw.fm/lGR3E
About Tilray®
Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients in eleven countries spanning five continents. For more information, visit the company’s website at www.Tilray.com.
More from CannabisNewsBreaks
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
